The role of lncRNA HCG18 in human diseases. | The role of lncRNA HCG18 in human diseases. Long F, Zhou X, Zhang J, Di C, Li X, Ye H, Pan J, Si J. | 03/5/2024 |
Molecular mechanisms of HCG18 in the sorafenib resistance of hepatocellular carcinoma. | Molecular mechanisms of HCG18 in the sorafenib resistance of hepatocellular carcinoma. Li H, Hu J, Qiu L, Wu Y, Zhong B, Ye R, Xie B. | 12/28/2023 |
LncRNA HCG18 Promotes Osteosarcoma Cells Proliferation, Migration, and Invasion in by Regulating miR-34a/RUNX2 Pathway. | LncRNA HCG18 Promotes Osteosarcoma Cells Proliferation, Migration, and Invasion in by Regulating miR-34a/RUNX2 Pathway. Chen YP, Zhang DX, Cao Q, He CK. | 06/23/2023 |
Exosomal lncRNA HCG18 contributes to cholangiocarcinoma growth and metastasis through mediating miR-424-5p/SOX9 axis through PI3K/AKT pathway. | Exosomal lncRNA HCG18 contributes to cholangiocarcinoma growth and metastasis through mediating miR-424-5p/SOX9 axis through PI3K/AKT pathway. Ni Q, Zhang H, Shi X, Li X., Free PMC Article | 04/19/2023 |
The role of long non-coding RNA HCG18 in cancer. | The role of long non-coding RNA HCG18 in cancer. Wang Z, Ran R, Zhang S, Zhou W, Lv J, Ma C, Zhang H. | 02/23/2023 |
Silencing lncRNA HCG18 regulates GPX4-inhibited ferroptosis by adsorbing miR-450b-5p to avert sorafenib resistance in hepatocellular carcinoma. | Silencing lncRNA HCG18 regulates GPX4-inhibited ferroptosis by adsorbing miR-450b-5p to avert sorafenib resistance in hepatocellular carcinoma. Li X, Li Y, Lian P, Lv Q, Liu F. | 02/16/2023 |
Long non-coding RNA human leucocyte antigen complex group-18 HCG18 (HCG18) promoted cell proliferation and migration in head and neck squamous cell carcinoma through cyclin D1-WNT pathway. | Long non-coding RNA human leucocyte antigen complex group-18 HCG18 (HCG18) promoted cell proliferation and migration in head and neck squamous cell carcinoma through cyclin D1-WNT pathway. Mao B, Wang F, Zhang J, Li Q, Ying K., Free PMC Article | 04/23/2022 |
LncRNA HCG18 promotes osteosarcoma growth by enhanced aerobic glycolysis via the miR-365a-3p/PGK1 axis. | LncRNA HCG18 promotes osteosarcoma growth by enhanced aerobic glycolysis via the miR-365a-3p/PGK1 axis. Pan X, Guo J, Liu C, Pan Z, Yang Z, Yao X, Yuan J., Free PMC Article | 04/23/2022 |
Long non-coding RNA HCG18 promotes gastric cancer progression by regulating miRNA-146a-5p/tumor necrosis factor receptor-associated factor 6 axis. | Long non-coding RNA HCG18 promotes gastric cancer progression by regulating miRNA-146a-5p/tumor necrosis factor receptor-associated factor 6 axis. Yang X, Liu R., Free PMC Article | 04/16/2022 |
LncRNA HCG18 upregulates TRAF4/TRAF5 to facilitate proliferation, migration and EMT of epithelial ovarian cancer by targeting miR-29a/b. | LncRNA HCG18 upregulates TRAF4/TRAF5 to facilitate proliferation, migration and EMT of epithelial ovarian cancer by targeting miR-29a/b. Zhang F, Luo BH, Wu QH, Li QL, Yang KD., Free PMC Article | 04/2/2022 |
LncRNA HCG18 suppresses CD8(+) T cells to confer resistance to cetuximab in colorectal cancer via miR-20b-5p/PD-L1 axis. | LncRNA HCG18 suppresses CD8(+) T cells to confer resistance to cetuximab in colorectal cancer via miR-20b-5p/PD-L1 axis. Xu YJ, Zhao JM, Ni XF, Wang W, Hu WW, Wu CP. | 03/26/2022 |
Long non-coding RNA HLA complex group 18 promotes gastric cancer progression by targeting microRNA-370-3p expression. | Long non-coding RNA HLA complex group 18 promotes gastric cancer progression by targeting microRNA-370-3p expression. Yuan Z, Zhang Y, Chen P, Liu S, Xin L, Liu C. | 03/19/2022 |
Long noncoding RNA HCG18 facilitates the progression of laryngeal and hypopharyngeal squamous cell carcinoma by upregulating FGFR1 via miR133b. | Long non‑coding RNA HCG18 facilitates the progression of laryngeal and hypopharyngeal squamous cell carcinoma by upregulating FGFR1 via miR‑133b. Peng H, Ge P., Free PMC Article | 03/12/2022 |
lncRNA HLA Complex Group 18 (HCG18) Facilitated Cell Proliferation, Invasion, and Migration of Prostate Cancer Through Modulating miR-370-3p/DDX3X Axis. | lncRNA HLA Complex Group 18 (HCG18) Facilitated Cell Proliferation, Invasion, and Migration of Prostate Cancer Through Modulating miR-370-3p/DDX3X Axis. Pan X, Chen G, Hu W. | 03/12/2022 |
Knockdown of HCG18 Inhibits Cell Viability, Migration and Invasion in Pediatric Osteosarcoma by Targeting miR-188-5p/FOXC1 Axis. | Knockdown of HCG18 Inhibits Cell Viability, Migration and Invasion in Pediatric Osteosarcoma by Targeting miR-188-5p/FOXC1 Axis. Zhao Z, Chen J, Xia D. | 01/8/2022 |
LncRNA-HCG18 regulates the viability, apoptosis, migration, invasion and epithelial-mesenchymal transition of papillary thyroid cancer cells via regulating the miR-106a-5p/PPP2R2A axis. | LncRNA-HCG18 regulates the viability, apoptosis, migration, invasion and epithelial-mesenchymal transition of papillary thyroid cancer cells via regulating the miR-106a-5p/PPP2R2A axis. Zhu Y, Zhao J, Tan L, Lin S, Long M, Peng X. | 11/27/2021 |
Identification of HCG18 and MCM3AP-AS1 That Associate With Bone Metastasis, Poor Prognosis and Increased Abundance of M2 Macrophage Infiltration in Prostate Cancer. | Identification of HCG18 and MCM3AP-AS1 That Associate With Bone Metastasis, Poor Prognosis and Increased Abundance of M2 Macrophage Infiltration in Prostate Cancer. Chen Y, Chen Z, Mo J, Pang M, Chen Z, Feng F, Xie P, Yang B., Free PMC Article | 11/27/2021 |
Long noncoding RNA HCG18 inhibits the differentiation of human bone marrow-derived mesenchymal stem cells in osteoporosis by targeting miR-30a-5p/NOTCH1 axis. | Long noncoding RNA HCG18 inhibits the differentiation of human bone marrow-derived mesenchymal stem cells in osteoporosis by targeting miR-30a-5p/NOTCH1 axis. Che M, Gong W, Zhao Y, Liu M., Free PMC Article | 08/14/2021 |
Long noncoding RNA HCG18 up-regulates the expression of WIPF1 and YAP/TAZ by inhibiting miR-141-3p in gastric cancer. | Long noncoding RNA HCG18 up-regulates the expression of WIPF1 and YAP/TAZ by inhibiting miR-141-3p in gastric cancer. Liu Y, Lin W, Dong Y, Li X, Lin Z, Jia J, Zou W, Pan Y., Free PMC Article | 07/24/2021 |
LncRNA HCG18 contributes to the progression of hepatocellular carcinoma via miR-214-3p/CENPM axis. | LncRNA HCG18 contributes to the progression of hepatocellular carcinoma via miR-214-3p/CENPM axis. Zou Y, Sun Z, Sun S. | 03/6/2021 |
LncRNA HCG18 contributes to nasopharyngeal carcinoma development by modulating miR-140/CCND1 and Hedgehog signaling pathway. | LncRNA HCG18 contributes to nasopharyngeal carcinoma development by modulating miR-140/CCND1 and Hedgehog signaling pathway. Li L, Ma TT, Ma YH, Jiang YF. | 10/24/2020 |
Low HCG18 expression is associated with proliferation and migration of bladder cancer. | NOTCH1 regulates the proliferation and migration of bladder cancer cells by cooperating with long non-coding RNA HCG18 and microRNA-34c-5p. Xu Z, Huang B, Zhang Q, He X, Wei H, Zhang D. | 07/11/2020 |